MENLO PARK, Calif. — The avenue known as Sand Hill Road is lined with low-slung, beige-hued buildings, interspersed with sunny courtyards and flowing fountains. If you didn’t know better, you could easily confuse venture capital’s Main Street for a resort.

Up-and-coming tech CEOs have long been making the pilgrimage here for an all-important 50-minute meeting with Andreessen Horowitz, among the most prestigious of the many VC firms that have set up shop in the area. Now, more and more life sciences entrepreneurs are scoring meetings, too.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • The obvious should be noted: Biotech’s birthplace is the Bay Area, and its size there is still a multiple of that of the Boston Area, which admittingly also has tech. Maybe its more a difference between West and East Coast.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy